14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.95 $2.61 Tuesday, 23rd Apr 2024 CHRS stock ended at $2.18. During the day the stock fluctuated 6.90% from a day low at $2.10 to a day high of $2.25.
90 days $1.93 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Dec 03, 2020 $18.89 $18.94 $18.53 $18.60 415 310
Dec 02, 2020 $18.70 $19.12 $18.31 $18.85 636 410
Dec 01, 2020 $18.80 $18.85 $18.32 $18.68 815 269
Nov 30, 2020 $18.53 $18.71 $18.16 $18.46 570 718
Nov 27, 2020 $18.11 $18.62 $18.08 $18.62 337 536
Nov 25, 2020 $18.79 $18.79 $17.91 $18.05 1 082 106
Nov 24, 2020 $18.69 $18.90 $18.25 $18.70 658 301
Nov 23, 2020 $18.48 $18.58 $18.15 $18.48 632 938
Nov 20, 2020 $17.78 $18.30 $17.66 $18.18 592 786
Nov 19, 2020 $17.75 $18.10 $17.69 $17.92 419 639
Nov 18, 2020 $17.88 $18.24 $17.68 $17.81 793 501
Nov 17, 2020 $17.85 $17.88 $17.18 $17.76 757 406
Nov 16, 2020 $18.28 $18.28 $17.59 $18.02 986 005
Nov 13, 2020 $18.06 $18.40 $17.78 $17.84 419 821
Nov 12, 2020 $18.22 $18.32 $17.75 $17.83 459 129
Nov 11, 2020 $18.65 $18.77 $17.98 $18.22 641 726
Nov 10, 2020 $18.02 $18.71 $17.73 $18.47 990 468
Nov 09, 2020 $17.29 $18.13 $17.08 $17.79 1 178 510
Nov 06, 2020 $17.22 $17.50 $16.45 $16.68 1 577 862
Nov 05, 2020 $18.07 $18.66 $18.07 $18.28 978 580
Nov 04, 2020 $17.07 $18.48 $17.07 $18.05 1 236 101
Nov 03, 2020 $16.84 $17.23 $16.62 $17.08 1 068 497
Nov 02, 2020 $16.89 $17.05 $16.44 $16.60 732 758
Oct 30, 2020 $17.07 $17.41 $16.49 $16.67 847 952
Oct 29, 2020 $17.14 $17.42 $16.77 $17.15 822 726
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT